Global Cholera Vaccines Market Size study & Forecast, by Vaccine Type (Whole cell V. cholerae O1 with Recombinant B-subunit, and Killed Oral O1, and O139), by Product (Vaxchora, Dukoral, Shanchol and Other Products) and Regional Analysis, 2022-2029
Global Cholera Vaccines Market is valued at approximately USD 86.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2022-2029. Vibrio cholera, which causes cholera, is spread by the intake of contaminated food or water. The infected people experience acute watery diarrhea, which eventually results in dehydration. If this condition is left untreated, the water loss might result in death. In order to avoid cholera epidemics, oral immunization has been found to be the most effective prophylactic measure. The market growth is driven by key players such as high incidence of cholera and rise in the number of initiatives to control cholera
The market for cholera vaccines is expanding as a result of several causes, including rising public and private sector activities, rising cholera prevalence, and increased global awareness of the disease. According to the World Health Organization, there were between 1.3 to 1.4 million cases of cholera reported in 2020 throughout all nations, including 17 in Africa, 12 in Asia, 4 in Europe, and 4 in the Americas. Eighty percent of all cases were in Haiti, the Demographic Republic of the Congo, Vietnam, Yemen, Peru, Somalia, and Tanzania. However, adverse effects of vaccines stifle market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cholera Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is recorded to be the largest region owing to high incidence rate, growing awareness, and availability of efficient preventive solutions. However, North America is expected to be the fastest growing region due to number of people traveling to countries with sudden outbreaks of cholera is increasing and demand for immunization is growing.
Major market players included in this report are:
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
AstraZeneca
GlaxoSmithKline plc (GSK)
Shantha Biotechnics Private Limited
Valneva SE
Astellas Pharma, Inc.
Emergent BioSolutions, Inc.
Pfizer, Inc.
Merck & Co., Inc.
Recent Developments in the Market:
In May 2022, more than 1.9 million children in Malawi are the target of a cholera immunisation campaign started by the World Health Organization Africa.
In June 2022, an oral cholera immunisation programme was started by the Ministry of Health and Partners in the Juba Country of Central Equatoria State. The campaign is a component of a plan of action to stop cholera outbreaks in the identified hotspot region.
Global Cholera Vaccines Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Vaccine type, Product, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Vaxchora
Dukoral
Shanchol
Other Products
By Vaccine Type:
Whole cell V. cholerae O1 with Recombinant B-subunit
Killed Oral O1 and O139
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
The market for cholera vaccines is expanding as a result of several causes, including rising public and private sector activities, rising cholera prevalence, and increased global awareness of the disease. According to the World Health Organization, there were between 1.3 to 1.4 million cases of cholera reported in 2020 throughout all nations, including 17 in Africa, 12 in Asia, 4 in Europe, and 4 in the Americas. Eighty percent of all cases were in Haiti, the Demographic Republic of the Congo, Vietnam, Yemen, Peru, Somalia, and Tanzania. However, adverse effects of vaccines stifle market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cholera Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is recorded to be the largest region owing to high incidence rate, growing awareness, and availability of efficient preventive solutions. However, North America is expected to be the fastest growing region due to number of people traveling to countries with sudden outbreaks of cholera is increasing and demand for immunization is growing.
Major market players included in this report are:
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
AstraZeneca
GlaxoSmithKline plc (GSK)
Shantha Biotechnics Private Limited
Valneva SE
Astellas Pharma, Inc.
Emergent BioSolutions, Inc.
Pfizer, Inc.
Merck & Co., Inc.
Recent Developments in the Market:
In May 2022, more than 1.9 million children in Malawi are the target of a cholera immunisation campaign started by the World Health Organization Africa.
In June 2022, an oral cholera immunisation programme was started by the Ministry of Health and Partners in the Juba Country of Central Equatoria State. The campaign is a component of a plan of action to stop cholera outbreaks in the identified hotspot region.
Global Cholera Vaccines Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Vaccine type, Product, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Vaxchora
Dukoral
Shanchol
Other Products
By Vaccine Type:
Whole cell V. cholerae O1 with Recombinant B-subunit
Killed Oral O1 and O139
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Cholera Vaccine Market, by Region, 2019-2029 (USD Million)
1.2.2. Cholera Vaccine Market, by Vaccine Type, 2019-2029 (USD Million)
1.2.3. Cholera Vaccine Market, by Product, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CHOLERA VACCINE MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CHOLERA VACCINE MARKET DYNAMICS
3.1. Cholera Vaccine Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. High incidence of cholera
3.1.1.2. Rise in the number of initiatives to control cholera
3.1.2. Market Challenges
3.1.2.1. Adverse effects of vaccines
3.1.3. Market Opportunities
3.1.3.1. Rising awareness about cholera preventive care
3.1.3.2. Rise in cholera vaccines across the world
CHAPTER 4. GLOBAL CHOLERA VACCINE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL CHOLERA VACCINE MARKET, BY VACCINE TYPE
6.1. Market Snapshot
6.2. Global Cholera Vaccine Market by Vaccine Type, Performance - Potential Analysis
6.3. Global Cholera Vaccine Market Estimates & Forecasts by Vaccine Type 2019-2029 (USD Million)
6.4. Cholera Vaccine Market, Sub Segment Analysis
6.4.1. Whole cell V. cholerae O1 with Recombinant B-subunit
6.4.2. Killed Oral O1 and O139
CHAPTER 7. GLOBAL CHOLERA VACCINE MARKET, BY PRODUCT
7.1. Market Snapshot
7.2. Global Cholera Vaccine Market by Product, Performance - Potential Analysis
7.3. Global Cholera Vaccine Market Estimates & Forecasts by Product 2019-2029 (USD Million)
7.4. Cholera Vaccine Market, Sub Segment Analysis
7.4.1. Vaxchora
7.4.2. Dukoral
7.4.3. Shanchol
7.4.4. Other Products
CHAPTER 8. GLOBAL CHOLERA VACCINE MARKET, REGIONAL ANALYSIS
8.1. Cholera Vaccine Market, Regional Market Snapshot
8.2. North America Cholera Vaccine Market
8.2.1. U.S. Cholera Vaccine Market
8.2.1.1. Vaccine Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Product breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Cholera Vaccine Market
8.3. Europe Cholera Vaccine Market Snapshot
8.3.1. U.K. Cholera Vaccine Market
8.3.2. Germany Cholera Vaccine Market
8.3.3. France Cholera Vaccine Market
8.3.4. Spain Cholera Vaccine Market
8.3.5. Italy Cholera Vaccine Market
8.3.6. Rest of Europe Cholera Vaccine Market
8.4. Asia-Pacific Cholera Vaccine Market Snapshot
8.4.1. China Cholera Vaccine Market
8.4.2. India Cholera Vaccine Market
8.4.3. Japan Cholera Vaccine Market
8.4.4. Australia Cholera Vaccine Market
8.4.5. South Korea Cholera Vaccine Market
8.4.6. Rest of Asia Pacific Cholera Vaccine Market
8.5. Latin America Cholera Vaccine Market Snapshot
8.5.1. Brazil Cholera Vaccine Market
8.5.2. Mexico Cholera Vaccine Market
8.5.3. Rest of Latin America Cholera Vaccine Market
8.6. Rest of The World Cholera Vaccine Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Mitsubishi Tanabe Pharma Corporation
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Takeda Pharmaceutical Co., Ltd.
9.2.3. AstraZeneca
9.2.4. GlaxoSmithKline plc (GSK)
9.2.5. Shantha Biotechnics Private Limited
9.2.6. Valneva SE
9.2.7. Astellas Pharma, Inc.
9.2.8. Emergent BioSolutions, Inc.
9.2.9. Pfizer, Inc.
9.2.10. Merck & Co., Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Cholera Vaccine Market, by Region, 2019-2029 (USD Million)
1.2.2. Cholera Vaccine Market, by Vaccine Type, 2019-2029 (USD Million)
1.2.3. Cholera Vaccine Market, by Product, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CHOLERA VACCINE MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CHOLERA VACCINE MARKET DYNAMICS
3.1. Cholera Vaccine Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. High incidence of cholera
3.1.1.2. Rise in the number of initiatives to control cholera
3.1.2. Market Challenges
3.1.2.1. Adverse effects of vaccines
3.1.3. Market Opportunities
3.1.3.1. Rising awareness about cholera preventive care
3.1.3.2. Rise in cholera vaccines across the world
CHAPTER 4. GLOBAL CHOLERA VACCINE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL CHOLERA VACCINE MARKET, BY VACCINE TYPE
6.1. Market Snapshot
6.2. Global Cholera Vaccine Market by Vaccine Type, Performance - Potential Analysis
6.3. Global Cholera Vaccine Market Estimates & Forecasts by Vaccine Type 2019-2029 (USD Million)
6.4. Cholera Vaccine Market, Sub Segment Analysis
6.4.1. Whole cell V. cholerae O1 with Recombinant B-subunit
6.4.2. Killed Oral O1 and O139
CHAPTER 7. GLOBAL CHOLERA VACCINE MARKET, BY PRODUCT
7.1. Market Snapshot
7.2. Global Cholera Vaccine Market by Product, Performance - Potential Analysis
7.3. Global Cholera Vaccine Market Estimates & Forecasts by Product 2019-2029 (USD Million)
7.4. Cholera Vaccine Market, Sub Segment Analysis
7.4.1. Vaxchora
7.4.2. Dukoral
7.4.3. Shanchol
7.4.4. Other Products
CHAPTER 8. GLOBAL CHOLERA VACCINE MARKET, REGIONAL ANALYSIS
8.1. Cholera Vaccine Market, Regional Market Snapshot
8.2. North America Cholera Vaccine Market
8.2.1. U.S. Cholera Vaccine Market
8.2.1.1. Vaccine Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Product breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Cholera Vaccine Market
8.3. Europe Cholera Vaccine Market Snapshot
8.3.1. U.K. Cholera Vaccine Market
8.3.2. Germany Cholera Vaccine Market
8.3.3. France Cholera Vaccine Market
8.3.4. Spain Cholera Vaccine Market
8.3.5. Italy Cholera Vaccine Market
8.3.6. Rest of Europe Cholera Vaccine Market
8.4. Asia-Pacific Cholera Vaccine Market Snapshot
8.4.1. China Cholera Vaccine Market
8.4.2. India Cholera Vaccine Market
8.4.3. Japan Cholera Vaccine Market
8.4.4. Australia Cholera Vaccine Market
8.4.5. South Korea Cholera Vaccine Market
8.4.6. Rest of Asia Pacific Cholera Vaccine Market
8.5. Latin America Cholera Vaccine Market Snapshot
8.5.1. Brazil Cholera Vaccine Market
8.5.2. Mexico Cholera Vaccine Market
8.5.3. Rest of Latin America Cholera Vaccine Market
8.6. Rest of The World Cholera Vaccine Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Mitsubishi Tanabe Pharma Corporation
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Takeda Pharmaceutical Co., Ltd.
9.2.3. AstraZeneca
9.2.4. GlaxoSmithKline plc (GSK)
9.2.5. Shantha Biotechnics Private Limited
9.2.6. Valneva SE
9.2.7. Astellas Pharma, Inc.
9.2.8. Emergent BioSolutions, Inc.
9.2.9. Pfizer, Inc.
9.2.10. Merck & Co., Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Cholera Vaccine Market, report scope
TABLE 2. Global Cholera Vaccine Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Cholera Vaccine Market estimates & forecasts by Vaccine Type 2019-2029 (USD Million)
TABLE 4. Global Cholera Vaccine Market estimates & forecasts by Product 2019-2029 (USD Million)
TABLE 5. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 6. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. U.S. Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 17. U.S. Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. Canada Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 19. Canada Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 20. Canada Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. UK Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 22. UK Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 23. UK Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. Germany Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 25. Germany Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 26. Germany Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. France Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 28. France Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 29. France Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. Italy Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 31. Italy Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 32. Italy Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Spain Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 34. Spain Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 35. Spain Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. RoE Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 37. RoE Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 38. RoE Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. China Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 40. China Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 41. China Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. India Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 43. India Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 44. India Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. Japan Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 46. Japan Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 47. Japan Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. South Korea Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 49. South Korea Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 50. South Korea Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. Australia Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 52. Australia Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 53. Australia Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. RoAPAC Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 55. RoAPAC Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 56. RoAPAC Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. Brazil Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 58. Brazil Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 59. Brazil Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Mexico Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 61. Mexico Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 62. Mexico Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. RoLA Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 64. RoLA Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 65. RoLA Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. Row Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 67. Row Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 68. Row Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Cholera Vaccine Market
TABLE 70. List of primary sources, used in the study of global Cholera Vaccine Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Cholera Vaccine Market, report scope
TABLE 2. Global Cholera Vaccine Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Cholera Vaccine Market estimates & forecasts by Vaccine Type 2019-2029 (USD Million)
TABLE 4. Global Cholera Vaccine Market estimates & forecasts by Product 2019-2029 (USD Million)
TABLE 5. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 6. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. U.S. Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 17. U.S. Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. Canada Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 19. Canada Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 20. Canada Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. UK Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 22. UK Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 23. UK Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. Germany Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 25. Germany Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 26. Germany Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. France Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 28. France Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 29. France Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. Italy Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 31. Italy Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 32. Italy Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Spain Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 34. Spain Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 35. Spain Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. RoE Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 37. RoE Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 38. RoE Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. China Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 40. China Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 41. China Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. India Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 43. India Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 44. India Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. Japan Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 46. Japan Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 47. Japan Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. South Korea Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 49. South Korea Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 50. South Korea Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. Australia Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 52. Australia Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 53. Australia Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. RoAPAC Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 55. RoAPAC Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 56. RoAPAC Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. Brazil Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 58. Brazil Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 59. Brazil Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Mexico Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 61. Mexico Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 62. Mexico Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. RoLA Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 64. RoLA Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 65. RoLA Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. Row Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 67. Row Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 68. Row Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Cholera Vaccine Market
TABLE 70. List of primary sources, used in the study of global Cholera Vaccine Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Cholera Vaccine Market, research methodology
FIG 2. Global Cholera Vaccine Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cholera Vaccine Market, key trends 2021
FIG 5. Global Cholera Vaccine Market, growth prospects 2022-2029
FIG 6. Global Cholera Vaccine Market, porters 5 force model
FIG 7. Global Cholera Vaccine Market, pest analysis
FIG 8. Global Cholera Vaccine Market, value chain analysis
FIG 9. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Cholera Vaccine Market, regional snapshot 2019 & 2029
FIG 15. North America Cholera Vaccine Market 2019 & 2029 (USD Million)
FIG 16. Europe Cholera Vaccine Market 2019 & 2029 (USD Million)
FIG 17. Asia Pacific Cholera Vaccine Market 2019 & 2029 (USD Million)
FIG 18. Latin America Cholera Vaccine Market 2019 & 2029 (USD Million)
FIG 19. Global Cholera Vaccine Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Cholera Vaccine Market, research methodology
FIG 2. Global Cholera Vaccine Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cholera Vaccine Market, key trends 2021
FIG 5. Global Cholera Vaccine Market, growth prospects 2022-2029
FIG 6. Global Cholera Vaccine Market, porters 5 force model
FIG 7. Global Cholera Vaccine Market, pest analysis
FIG 8. Global Cholera Vaccine Market, value chain analysis
FIG 9. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Cholera Vaccine Market, regional snapshot 2019 & 2029
FIG 15. North America Cholera Vaccine Market 2019 & 2029 (USD Million)
FIG 16. Europe Cholera Vaccine Market 2019 & 2029 (USD Million)
FIG 17. Asia Pacific Cholera Vaccine Market 2019 & 2029 (USD Million)
FIG 18. Latin America Cholera Vaccine Market 2019 & 2029 (USD Million)
FIG 19. Global Cholera Vaccine Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
